1
|
Obiora D, Orikogbo O, Davies BJ, Jacobs BL. Controversies in prostate cancer screening. Urol Oncol 2024:S1078-1439(24)00534-9. [PMID: 39127529 DOI: 10.1016/j.urolonc.2024.06.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2024] [Revised: 05/10/2024] [Accepted: 06/17/2024] [Indexed: 08/12/2024]
Abstract
Prostate cancer is the second most diagnosed cancer and the fifth leading cause of cancer death among men worldwide. In the 1980s, the development and implementation of Prostate-Specific Antigen (PSA) testing for diagnosing prostate cancer led to a surge in the number of prostate cancer diagnoses. We explore the trends in recommendations and new innovations in adjunctive testing for prostate cancer screening.
Collapse
Affiliation(s)
- Daisy Obiora
- Division of Health Services Research, Department of Urology, University of Pittsburgh Medical Center
| | - Oluwaseun Orikogbo
- Division of Health Services Research, Department of Urology, University of Pittsburgh Medical Center
| | - Benjamin J Davies
- Division of Health Services Research, Department of Urology, University of Pittsburgh Medical Center
| | - Bruce L Jacobs
- Division of Health Services Research, Department of Urology, University of Pittsburgh Medical Center.
| |
Collapse
|
2
|
Feng Y, Huo Q, Li BY, Yokota H. Unveiling the Dichotomy of Urinary Proteins: Diagnostic Insights into Breast and Prostate Cancer and Their Roles. Proteomes 2023; 12:1. [PMID: 38250812 PMCID: PMC10801584 DOI: 10.3390/proteomes12010001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2023] [Revised: 12/21/2023] [Accepted: 12/22/2023] [Indexed: 01/23/2024] Open
Abstract
This review covers the diagnostic potential of urinary biomarkers, shedding light on their linkage to cancer progression. Urinary biomarkers offer non-invasive avenues for detecting cancers, potentially bypassing the invasiveness of biopsies. The investigation focuses primarily on breast and prostate cancers due to their prevalence among women and men, respectively. The intricate interplay of urinary proteins is explored, revealing a landscape where proteins exhibit context-dependent behaviors. The review highlights the potential impact of physical activity on urinary proteins, suggesting its influence on tumorigenic behaviors. Exercise-conditioned urine may emerge as a potential diagnostic biomarker source. Furthermore, treatment effects, notably after lumpectomy and prostatectomy, induce shifts in the urinary proteome, indicating therapeutic impacts rather than activating oncogenic signaling. The review suggests further investigations into the double-sided, context-dependent nature of urinary proteins, the potential role of post-translational modifications (PTM), and the integration of non-protein markers like mRNA and metabolites. It also discusses a linkage of urinary proteomes with secretomes from induced tumor-suppressing cells (iTSCs). Despite challenges like cancer heterogeneity and sample variability due to age, diet, and comorbidities, harnessing urinary proteins and proteoforms may hold promise for advancing our understanding of cancer progressions, as well as the diagnostic and therapeutic role of urinary proteins.
Collapse
Affiliation(s)
- Yan Feng
- Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310022, China;
| | - Qingji Huo
- Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China;
- Department of Biomedical Engineering, Indiana University Purdue University Indianapolis, Indianapolis, IN 46202, USA
| | - Bai-Yan Li
- Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin 150081, China;
| | - Hiroki Yokota
- Department of Biomedical Engineering, Indiana University Purdue University Indianapolis, Indianapolis, IN 46202, USA
- Indiana Center for Musculoskeletal Health, Indiana University School of Medicine, Indianapolis, IN 46202, USA
- Indiana University Simon Comprehensive Cancer Center, Indianapolis, IN 46202, USA
| |
Collapse
|
3
|
Chong RIH, Leow JJ, Choo ZW, Salada R, Yong DZP, Chong YL. Testicular self-examination for early detection of testicular cancer. World J Urol 2023; 41:941-951. [PMID: 37036497 DOI: 10.1007/s00345-023-04381-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2022] [Accepted: 03/14/2023] [Indexed: 04/11/2023] Open
Abstract
Testicular cancer (TCa) commonly presents as a painless scrotal mass. It has been suggested that testicular self-examination (TSE) can help in early detection and thus potentially improve treatment outcomes and prognosis. While TSE is more well established in guideline recommendations for patients with a known history of TCa, its role in healthy young men is less established and controversial. In this paper, we review contemporary data to provide an updated recommendation.
Collapse
Affiliation(s)
- Ryan I H Chong
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
| | - Jeffrey J Leow
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Department of Urology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
| | - Zhen Wei Choo
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
- Department of Urology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
| | - Rolando Salada
- Department of Urology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore
| | - Daniel Z P Yong
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
- Department of Urology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
| | - Yew-Lam Chong
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
- Department of Urology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore, 308433, Singapore
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
| |
Collapse
|
4
|
Foster S, Carvallo M, Wenske M, Lee J. Damaged Masculinity: How Honor Endorsement Can Influence Prostate Cancer Screening Decision-Making and Prostate Cancer Mortality Rates. PERSONALITY AND SOCIAL PSYCHOLOGY BULLETIN 2023; 49:296-308. [PMID: 34964413 DOI: 10.1177/01461672211065293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Prior research has established factors that contribute to the likelihood that men seek out prostate cancer screenings. The current study addresses how endorsing the ideology found in cultures of honor may serve as a barrier to prostate cancer screenings. Two studies were conducted which analyzed the impact of stigma on men's decisions to seek out prostate cancer screenings (Study 1) as well as how prostate cancer deaths may be higher in the culture of honor regions due to men's reticence to seek out screenings (Study 2). Results suggest that older, honor-endorsing men are less likely to have ever sought out a prostate cancer screening due to screening stigma and that an honor-oriented region (southern and western United States) displays higher rates of prostate cancer death than a non-honor-oriented region (northern United States). These findings suggest that honor may be a cultural framework to consider when practitioners address patients' screening-related concerns.
Collapse
Affiliation(s)
| | | | | | - Jongwon Lee
- The University of New Mexico, Albuquerque, USA
| |
Collapse
|
5
|
Prostate cancer screening: Continued controversies and novel biomarker advancements. Curr Urol 2022; 16:197-206. [PMID: 36714234 PMCID: PMC9875204 DOI: 10.1097/cu9.0000000000000145] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2022] [Accepted: 05/23/2022] [Indexed: 02/01/2023] Open
Abstract
Prostate cancer (PCa) screening remains one of the most controversial topics in clinical and public health. Despite being the second most common cancer in men worldwide, recommendations for screening using prostate-specific antigen (PSA) are unclear. Early detection and the resulting postscreening treatment lead to overdiagnosis and overtreatment of otherwise indolent cases. In addition, several unwanted harms are associated with PCa screening process. This literature review focuses on the limitations of PSA-specific PCa screening, reasons behind the screening controversy, and the novel biomarkers and advanced innovative methodologies that improve the limitations of traditional screening using PSA. With the verdict of whether or not to screen not yet unanimous, we hope to aid in resolution of the long-standing debate.
Collapse
|
6
|
Lehrer SP. Obesity and aggressive prostate cancer. Cancer 2020; 126:2319. [PMID: 32022896 DOI: 10.1002/cncr.32761] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2019] [Accepted: 01/15/2020] [Indexed: 11/12/2022]
Affiliation(s)
- Steven P Lehrer
- Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, New York
| |
Collapse
|
7
|
Butler SS, Mahal BA. Reply to Obesity and aggressive prostate cancer and the golden rule: Do not do to others what you do not want done to yourself. Cancer 2020; 126:2321-2322. [PMID: 32022907 DOI: 10.1002/cncr.32758] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2020] [Accepted: 01/15/2020] [Indexed: 11/08/2022]
Affiliation(s)
- Santino S Butler
- Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
| | - Brandon A Mahal
- Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
| |
Collapse
|
8
|
Joshi SS, Filson CP. Reply to Obesity and aggressive prostate cancer and the golden rule: Do not do to others what you do not want done to yourself. Cancer 2020; 126:2322-2323. [PMID: 32022901 DOI: 10.1002/cncr.32759] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2020] [Accepted: 01/15/2020] [Indexed: 11/09/2022]
Affiliation(s)
- Shreyas S Joshi
- Department of Urology, Emory University School of Medicine, Atlanta, Georgia
| | | |
Collapse
|
9
|
Takahashi TF. The golden rule: Do not do to others what you do not want done to yourself. Cancer 2020; 126:2319-2320. [DOI: 10.1002/cncr.32760] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2019] [Accepted: 01/15/2020] [Indexed: 11/10/2022]
|
10
|
Xie S, Li B, Lyu P, Kwok HF, Ge L, Wu Q. A new voltammetric immunosensing platform for prostate-specific antigen based on the Cu(ii)-pyrophosphate ion chelation reaction. NEW J CHEM 2020. [DOI: 10.1039/c9nj05514b] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
An electrochemical immunoassay was designed to detect prostate-specific antigenviapyrophosphatase-hydrolysed Cu(ii)-coordinated pyrophosphate ion with the capture of the releasing Cu(ii) ion.
Collapse
Affiliation(s)
- Shuping Xie
- Collaborative Innovation Center of Chinese Medicinal Resources Industrialization
- Nanjing University of Chinese Medicine
- Nanjing
- P. R. China
| | - Bin Li
- Collaborative Innovation Center of Chinese Medicinal Resources Industrialization
- Nanjing University of Chinese Medicine
- Nanjing
- P. R. China
| | - Peng Lyu
- College of Biological Science and Technology
- Fuzhou University
- Fuzhou
- P. R. China
| | - Hang Fai Kwok
- Cancer Centre
- Faculty of Health Sciences
- University of Macau
- Taipa
- Macau SAR
| | - Lilin Ge
- Collaborative Innovation Center of Chinese Medicinal Resources Industrialization
- Nanjing University of Chinese Medicine
- Nanjing
- P. R. China
| | - Qinan Wu
- Collaborative Innovation Center of Chinese Medicinal Resources Industrialization
- Nanjing University of Chinese Medicine
- Nanjing
- P. R. China
| |
Collapse
|